• news.cision.com/
  • OssDsign AB/
  • OssDsign’s Management and Board of Directors increase their long-term commitment through acquisiton of warrants for a total amount of approximately SEK 1.3 million
English

OssDsign’s Management and Board of Directors increase their long-term commitment through acquisiton of warrants for a total amount of approximately SEK 1.3 million

Report this content

Uppsala, Sweden, 08.00 CET, 1 July 2021 – OssDsign, a global provider of regenerative orthopedic solutions for treatment of patients who have suffered from cranial or spinal bone defects, today announces that its Management and Board of Directors have acquired 3.8m warrants under the 2021/2024 long-term incentive programme for a total amount of approximately SEK 1.3 million.

The largest individual participants in the incentive programme are the company’s CEO, CFO and Chairman:

  • Morten Henneveld (CEO) has aquired 1,712,235 warrants at an approximate cost of SEK 600 000
  • Anders Svensson (CFO) has aquired 428,058 warrants at an approximate cost of SEK 150 000
  • Simon Cartmell (Chairman of the Board) has acquired 285,372 warrants at an approximate cost of SEK 100 000

The warrants have been issued under a long-term incentive programme adopted by the Annual General Meeting on 22 June 2021. Each warrant gives right to subscribe for one new share during the period as from and including 1 July 2024 until and including 31 December 2024.

For further information, please contact:
Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com

Certified Adviser:
Erik Penser Bank AB is the company’s Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email: certifiedadviser@penser.se.

About OssDsign
OssDsign’s vision is to provide regenerative solutions to all patients with cranial or spinal bone defects, so they can be restored and healed as naturally as possible. Driven by a commitment to give patients back the lives they deserve, OssDsign collaborates with surgeons to engineer better healing by integrating biomaterials with clinical design. Headquartered in Sweden, OssDsign supplies hospitals worldwide with implants for use in cranial reconstructions and other orthopaedic surgery applications.

Tags:

OssDsign

Subscribe

Documents & Links